Ian Shakil, CHIEF STRATEGY OFFICER at Augmedix, Inc. (AUGX), sold 95,982 shares at $4.06 ($280K) on 2024-03-28, disclosed to the SEC on 2024-04-09.
Open-market sale of $280k AUGX by CHIEF STRATEGY OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.64 | 31,994 | $20K | 7.3% |
| 2 | $4.06 | 31,994 | $130K | 46.3% |
| 3 | $4.06 | 31,994 | $130K | 46.3% |
| Total | $2.92 avg | 95,982 | $280K | 100% |
| Filing → |
| AUGX | SELL | 2024-04-15 | $149K | — | Filing → |
| AUGX | SELL | 2024-04-11 | $738K | — | Filing → |
| AUGX | SELL | 2024-04-09 | $678K | — | Filing → |